Mangalore Refinery and Petrochemicals Limited (MRPL) is a schedule ‘A' Miniratna, Central Public Sector Enterprise (CPSE) under the Ministry of Petroleum & Natural Gas. MRPL is located in a beautiful hilly terrain, north of Mangaluru city, in Dakshina Kannada District of Karnataka State (India). The 15 Million Metric Tonne Refinery has got a versatile design with complex secondary processing units and a high flexibility to process Crudes of various API, delivering a variety of quality products.

Mangalore Refinery & Petrochemicals LTD - India

CA Industrial Trainee

Articled Assistant

Executive

Senior Manager Technical Services

Manager (Technical Services)

Senior Process Engineer

Technical Service Engineer

Front Office Associate

Assistant Engineer

Officer trainee E&I project quality

Project Intern

python

Assistant Manager (HR)

Junior Manager (HR)

Mechanical Engineer

Franchise Owner

Secretary

Software Engineer

Welding Inspector

Outlook

Google Tag Manager

reCAPTCHA

Google Analytics

Google Font API

Google AdSense

Manager Finance

Assistant Manager Finance

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business.Currently ranked 6th in the Indian pharmaceutical market, it's the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK.Intas operates 16 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 18,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable "Biosimilars for Billions" across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies.The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab.Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

Intas Pharmaceuticals

Microsoft Azure Hosting

WordPress.org

Ubuntu

Bootstrap Framework

ASSITANT MANAGER COSTING

Founded by Shri I.A. Modi, Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat. Over the last seven decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over hundred other countries around the world.Focused strongly on Innovation and Research, the company is present in more than forty-five therapeutic areas spread across twelve specialities, including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals.At Cadila Pharmaceuticals, Research and Development is at the core of all its initiatives, be it Biotechnology, APIs, Formulations, Plant Tissue Culture or Phytochemistry.More than 300 scientists in its various Research and Development setups reinforce the competitiveness of research in the therapeutic areas which have high unmet medical needs.Cadila Pharmaceuticals Excellence in manufacturing facilities is central to Cadila Pharmaceuticals. The company's formulations manufacturing plant at Dholka near Ahmedabad, Gujarat is spread over hundred acres of land. This state-of-the- art facility is not only impressive in size, but is also USFDA approved.The second formulations manufacturing facility is located at Samba in Jammu and Kashmir. The facility meets most of the stringent quality standards across the globe to produce tablets, capsules, soft and hard gelatin capsules, liquids and orals.Two Active Pharmaceutical Ingredient (API) manufacturing units at Ankleshwar, Gujarat manufacture a wide range of APIs and intermediates including many USFDA-certified products.The company has strong foothold in the African continent through its formulation manufacturing facility at Addis Ababa in Ethiopia.For more information visit: https://www.cadilapharma.com/

Hardik Jha

Manager Finance at Mangalore Refinery & Petrochemicals LTD - India

Hardik Jha's Professional Contact Details

Hardik Jha's Current Company Details

Mangalore Refinery & Petrochemicals LTD - India

Hardik Jha's Work History and Education

Others Named Hardik Jha

Frequently Asked Questions about Hardik Jha

What company does Hardik Jha work for?

What is Hardik Jha's role at Mangalore Refinery & Petrochemicals LTD - India?

What is Hardik Jha's email address?

What is Hardik Jha's business email address?

What is Hardik Jha's HQ phone number?

What industry does Hardik Jha work in?

Who are Hardik Jha's colleagues?

Colleagues at Mangalore Refinery & Petrochemicals LTD - India

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?